Education
About Us
Working with TipRanks
Follow Us
Celon Pharma SA (PL:CLN)
:CLN
CLN Stock Chart & Stats
zł20.95
--
Market closed
zł20.95
--
Day’s Range― - ―
52-Week Rangezł18.50 - zł28.65
Previous CloseN/A
VolumeN/A
Average Volume (3M)15.54K
Market Cap
€1.13B
Enterprise Valuezł1.20B
Total Cash (Recent Filing)€1.71M
Total Debt (Recent Filing)€14.19M
Price to Earnings (P/E)68.8
Beta0.49
Next Earnings
Apr 29, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield0.43%
Share Statistics
EPS (TTM)0.07
Shares Outstanding53,856,500
10 Day Avg. Volume8,893
30 Day Avg. Volume15,545
Financial Highlights & Ratios
PEG Ratio-2.02
Price to Book (P/B)3.12
Price to Sales (P/S)7.86
P/FCF Ratio-40.70
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusHold
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Celon Pharma SA News
CLN FAQ
What was Celon Pharma SA’s price range in the past 12 months?
Celon Pharma SA lowest stock price was zł18.50 and its highest was zł28.65 in the past 12 months.
What is Celon Pharma SA’s market cap?
Celon Pharma SA’s market cap is €1.13B.
When is Celon Pharma SA’s upcoming earnings report date?
Celon Pharma SA’s upcoming earnings report date is Apr 29, 2026 which is in 107 days.
How were Celon Pharma SA’s earnings last quarter?
Celon Pharma SA released its earnings results on Nov 19, 2025. The company reported zł0.068 earnings per share for the quarter, beating the consensus estimate of N/A by zł0.068.
Is Celon Pharma SA overvalued?
According to Wall Street analysts Celon Pharma SA’s price is currently Overvalued.
Does Celon Pharma SA pay dividends?
Celon Pharma SA pays a Annually dividend of zł0.298 which represents an annual dividend yield of 0.43%. See more information on Celon Pharma SA dividends here
What is Celon Pharma SA’s EPS estimate?
Celon Pharma SA’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Celon Pharma SA have?
Celon Pharma SA has 53,856,500 shares outstanding.
What happened to Celon Pharma SA’s price movement after its last earnings report?
Celon Pharma SA reported an EPS of zł0.068 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 0.233%.
Which hedge fund is a major shareholder of Celon Pharma SA?
Currently, no hedge funds are holding shares in PL:CLN
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Celon Pharma SA
Celon Pharma S.A., an integrated pharmaceutical company, researches, manufactures, and markets pharmaceutical products and preparations. The company operates through Generic Drug and Innovative segments. It offers drugs to treat cancers, neurological diseases, diabetes, and other metabolic disorders. The company was founded in 2002 and is based in Lomianki, Poland. Celon Pharma S.A. is a subsidiary of Glatton Sp. z o.o.
Technical Analysis
Ryvu Therapeutics SA
―
Captor Therapeutics SA
―
OncoArendi Therapeutics SA
―
Selvita SA
―
Mabion SA
―